A role for excitatory amino acids in diabetic eye disease

Jose E. Pulido, Jose S. Pulido, Jay C. Erie, Jorge Arroyo, Kurt Bertram, Miao Jen Lu, Scott A. Shippy

Research output: Contribution to journalReview article

50 Scopus citations

Abstract

Diabetic retinopathy is a leading cause of vision loss. The primary clinical hallmarks are vascular changes that appear to contribute to the loss of sight. In a number of neurodegenerative disorders there is an appreciation that increased levels of excitatory amino acids are excitotoxic. The primary amino acid responsible appears to be the neurotransmitter glutamate. This review examines the nature of glutamatergic signaling at the retina and the growing evidence from clinical and animal model studies that glutamate may be playing similar excitotoxic roles at the diabetic retina.

Original languageEnglish (US)
Article number36150
JournalExperimental Diabesity Research
Volume2007
DOIs
StatePublished - 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A role for excitatory amino acids in diabetic eye disease'. Together they form a unique fingerprint.

  • Cite this

    Pulido, J. E., Pulido, J. S., Erie, J. C., Arroyo, J., Bertram, K., Lu, M. J., & Shippy, S. A. (2007). A role for excitatory amino acids in diabetic eye disease. Experimental Diabesity Research, 2007, [36150]. https://doi.org/10.1155/2007/36150